BIOMAT Database Logo BIOMAT Database Logo

[Kanamycin: study of its antibacterial activity]. 1959

A CASSANO, and L NUZZOLO, and M RAVETTA

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics

Related Publications

A CASSANO, and L NUZZOLO, and M RAVETTA
Antibacterial activity of Kanamycin.
March 1958, Antibiotics & chemotherapy (Northfield, Ill.),
A CASSANO, and L NUZZOLO, and M RAVETTA
[THE ANTIBACTERIAL ACTION OF KANAMYCIN IN VITRO AND ITS CHEMOTHERAPEUTIC ACTIVITY].
February 1964, Antibiotiki,
A CASSANO, and L NUZZOLO, and M RAVETTA
Calcium inhibition of antibacterial activity of kanamycin.
August 1972, American journal of veterinary research,
A CASSANO, and L NUZZOLO, and M RAVETTA
Laboratory studies on the antibacterial activity of kanamycin.
August 1959, Antibiotics & chemotherapy (Northfield, Ill.),
A CASSANO, and L NUZZOLO, and M RAVETTA
[Antibacterial activity in vitro of ristocetin, kanamycin and farmiglucine].
December 1964, Bollettino della Societa italiana di biologia sperimentale,
A CASSANO, and L NUZZOLO, and M RAVETTA
[Antibacterial action of kanamycin].
June 1959, Medicina,
A CASSANO, and L NUZZOLO, and M RAVETTA
[Preliminary observations on the antibacterial activity of kanamycin in vitro & on its action in human tuberculosis].
January 1958, Giornale italiano della tubercolosi,
A CASSANO, and L NUZZOLO, and M RAVETTA
Antibacterial activity of the combination ampicillin-kanamycin against gram-negative bacteria.
May 1972, Pathologie-biologie,
A CASSANO, and L NUZZOLO, and M RAVETTA
Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity.
January 2016, Frontiers in microbiology,
A CASSANO, and L NUZZOLO, and M RAVETTA
[The present antibacterial spectrum of kanamycin].
February 1962, Annales de l'Institut Pasteur,
Copied contents to your clipboard!